Web Analytics

3 Latest Announced Rounds

$1,526.72M Raised in 61 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Sift Biosciences

start up
United States - San Carlos, CA
  • 19/02/2026
  • Pre-Seed
  • $3,700,000

Using AI and high-throughput T-cell screening, Sift is developing a new class of T-cell modulators to treat cancers and autoimmune diseases.


Related People

Yue Clare Lou, Ph.D.Co Founder

Yue Clare Lou, Ph.D. United States - San Francisco Bay Area

Scientist | Founder

Immunology | Cancer <> AI/Bioinformatics <> Microbiology